◆英語タイトル：Omega Pharma NV - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C4473
◆発行会社（調査会社）：
MarketLine
◆発行日：2018年8月
◆ページ数：29
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ベルギー
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
MarketLine社の概要はこちらでご確認いただけます。
Omega Pharma NV – Strategy, SWOT and Corporate Finance Report
Summary
Omega Pharma NV – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Omega Pharma NV (Omega or ‘the company’), is a subsidiary of Perrigo Company plc, is engaged in the development, marketing and sales of over-the-counter (OTC) pharmaceutical products. It also offers pain relief products, eye care products, sleep aid and anti-snoring products, slimming products, and home diagnostics. The company primarily operates in Europe. Omega is headquartered in Nazareth, Belgium.
Scope
- Detailed information on Omega Pharma NV required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Omega Pharma NV in the form of a SWOT analysis
- An in-depth view of the business model of Omega Pharma NV including a breakdown and examination of key business segments
- Intelligence on Omega Pharma NV’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Omega Pharma NV, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
- Gain understanding of Omega Pharma NV and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Omega Pharma NV as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Omega Pharma NV’s business structure, strategy and prospects.
Table of Contents
Company Snapshot 2
Table of Contents 4
Omega Pharma NV: Company Overview 7
Omega Pharma NV: Overview and Key Facts 7
Omega Pharma NV: Overview 7
Omega Pharma NV: Key Facts 7
Omega Pharma NV: Key Employees 9
Omega Pharma NV: Major Products and Services 10
Omega Pharma NV: Company History 11
Omega Pharma NV: Management Statement 14
Omega Pharma NV: Locations and Subsidiaries 15
Omega Pharma NV: Key Competitors 16
Omega Pharma NV: Company Analysis 17
Omega Pharma NV: Business Description 17
Omega Pharma NV: SWOT Analysis 18
Omega Pharma NV: SWOT Overview 18
Omega Pharma NV: Strengths 18
Omega Pharma NV: Weaknesses 19
Omega Pharma NV: Opportunities 19
Omega Pharma NV: Threats 20
Omega Pharma NV: Corporate Financial Deals Activity 21
Omega Pharma NV: Financial Deals Overview 21
Omega Pharma NV: Targets and Partners 23
Omega Pharma NV: Top Deals 2014 – 2018YTD* 24
Omega Pharma NV: Partnership 25
Omega Pharma NV: Private Equity and Ownership 26
Appendix 27
Contact Us 27
Methodology 27
About MarketLine 28
List of Tables
Table 1: Omega Pharma NV: Key Facts
Table 2: Omega Pharma NV: Key Employees
Table 3: Omega Pharma NV: Locations and Subsidiaries
Table 4: Omega Pharma NV: Key Competitors
Table 5: Omega Pharma NV: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Omega Pharma NV: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Omega Pharma NV: Targets and Partners
Table 8: Omega Pharma NV: Top Deals 2014 - 2018YTD*
Table 9: Omega Pharma NV: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 10: Omega Pharma NV: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 11: Omega Pharma NV: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 12: Omega Pharma NV: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
List of Figures
Figure 1: Omega Pharma NV: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Omega Pharma NV: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Omega Pharma NV: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 4: Omega Pharma NV: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 5: Omega Pharma NV: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 6: Omega Pharma NV: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
